Compare Sources
Two outlets side by side, or one story's headlines by leaning.
US FDA declines to approve Summit lung cancer drug after trial misses key survival goal
Left 20%20%Centre 60%60%Right 20%20%
Left 1 article
First: Quartz, 1 day ago
Centre 4 articles
First: Reuters, 2 days ago
- US FDA declines to approve Summit lung cancer drug after trial misses key survival goal - Reuters Reuters
- FDA Rejects Promising Cancer Drug Developed in China Medpagetoday
- US FDA approves Roche's oral treatment for advanced breast cancer - Reuters Reuters
- FDA Rejects China's Cancer Drug as 'Blow to Beijing' Framing Unleashes Fury Over American Lung Cancer Patients Ibtimes
Right 1 article
First: The Epoch Times, 1 day ago
How this was worked out
Headlines grouped by the leaning of their outlet. “Words this side uses more” are headline words at least 2.5 times more common on that side than on the other two, used by at least 2 of its outlets.
How INDB scores stories · Data: stories INDB grouped from the outlets on the sources page.